Final HIPAA omnibus rule goes into effect March 26
The final omnibus rule, which makes changes to the Health Insurance Portability and Accountability Act of 1996, goes into effect March 26, and physicians must be in compliance by Sept. 23.
(HealthDay)—The final omnibus rule, which makes changes to the Health Insurance Portability and Accountability Act (HIPAA) of 1996, goes into effect March 26, and physicians must be in compliance by Sept. 23.
The rule finalizes statutory changes in a section of the American Recovery and Reinvestment Act of 2009 as well as changes required by the Genetic Information Nondiscrimination Act of 2008. The final rule expands privacy requirements and security rules to business associates and subcontractors of physicians; establishes limitations on the use of personal health data for marketing and fundraising; prevents sale of patients' health information without specific authorization; extends the rights of patients to request and receive electronic copies of their medical records; and increases the patient's ability to limit disclosure of their health information to insurance plans.
The final omnibus rule is effective March 26. Physicians and other covered entities are expected to comply by Sept. 23. To ensure their practices are in compliance by the September deadline, physicians are encouraged to review their current policies and procedures with regard to HIPAA and patient health data.
"This final rule is needed to strengthen the privacy and security protections established under HIPAA for individual's health information maintained in electronic health records and other formats," according to the Jan. 25 Federal Register published by the U.S. Department of Health and Human Services. "This final rule also makes changes to the HIPAA rules that are designed to increase flexibility for and decrease burden on the regulated entities, as well as to harmonize certain requirements with those under the Department's Human Subjects Protections regulations."
More information: More Information
Health News Copyright © 2013 HealthDay. All rights reserved.
-
Internists address dual concerns of privacy and protection of health data
Oct 18, 2011 |
not rated yet |
0
-
FSIS makes mad cow rule permanent
Jul 12, 2007 |
not rated yet |
0
-
Canadian C-spine rule more accurate in diagnosing important cervical spine injuries than other rules
Oct 09, 2012 |
not rated yet |
0
-
US confirms contraception without co-pay rule
Jan 20, 2012 |
not rated yet |
0
-
HHS details overhaul rules and required benefits
Nov 20, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
It's not your imagination: Memory gets muddled at menopause
Don't doubt it when a woman harried by hot flashes says she's having a hard time remembering things. A new study published online in Menopause, the journal of The North American Menopause Society (NAMS), helps confirm with o ...
Health
24 minutes ago |
not rated yet |
0
Farm bill: Senate rejects GMO labeling amendment
The Senate has overwhelmingly rejected an amendment allowing states to require labeling of genetically modified foods.
Health
55 minutes ago |
not rated yet |
1
McDonald's can't shake criticism about nutrition
(AP)—McDonald's once again faced criticism that it's a purveyor of junk food that markets to children at its annual shareholder meeting Thursday.
Health
1 hour ago |
not rated yet |
0
Economic incentives increase blood donation without negative consequences
Can economic incentives such as gift cards, T-shirts, and time off from work motivate members of the public to increase their donations of blood?
Health
3 hours ago |
not rated yet |
0
|
Adult day services for dementia patients provide stress relief to family caregivers
Family caregivers of older adults with dementia are less stressed and their moods are improved on days when dementia patients receive adult day services (ADS), according to Penn State researchers.
Health
5 hours ago |
not rated yet |
0
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
Research identifies a way to make cancer cells more responsive to chemotherapy
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University ...
Mayo Clinic genomic analysis lends insight to prostate cancer
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...
Shortage of key drug hampering U.S. efforts to control TB, report says
(HealthDay)—A shortage of a critical tuberculosis drug has hampered the efforts of health departments across the United States to contain the spread of the highly infectious lung disease, federal officials ...
Heart healthy lifestyle may cut kidney disease patients' risk of kidney failure
Maintaining a heart healthy lifestyle may also help protect chronic kidney disease patients from developing kidney failure and dying prematurely, according to a study appearing in an upcoming issue of the Journal of the Am ...
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.